Search Results - Abelman, Rachel O

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer

    Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer by Bardia, Aditya, Sun, Sheng, Thimmiah, Nayana, Coates, James T, Wu, Bogang, Abelman, Rachel O, Spring, Laura, Moy, Beverly, Ryan, Phoebe, Melkonyan, Mark N, Partridge, Ann, Juric, Dejan, Peppercorn, Jeffrey, Parsons, Heather, Wander, Seth A, Attaya, Victoria, Lormil, Brenda, Shellock, Maria, Nagayama, Aiko, Bossuyt, Veerle, Isakoff, Steven J, Tolaney, Sara M, Ellisen, Leif W

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 5459: Association between stomatitis and treatment efficacy with novel TROP2-directed antibody drug conjugate (ADC), datopotamab deruxtecan, in patients with metastatic cancer

    Abstract 5459: Association between stomatitis and treatment efficacy with novel TROP2-directed antibody drug conjugate (ADC), datopotamab deruxtecan, in patients with metastatic ca... by Abelman, Rachel O., Spring, Laura M., Ryan, Phoebe K., Fell, Geoffrey, Juric, Dejan, Heist, Rebecca S., Bardia, Aditya

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: